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Abstract 
6-Phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase (FBPase-2) catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, 
a potent stimulator of glycolysis. Transcription of the mRNA encoding rat liver PFK-2/FBPase-2 is stimulated by insulin and by glucocorticoids 
in rat hepatoma cells. We show here that insulin can also prevent and reverse this glucocorticoid effect. The inhibitory effect of insulin is independent 
of extracellular glucose and does not require ongoing protein synthesis. We conclude that insulin exerts opposite effects on PFK-ZIFBPase-2 gene 
transcription depending on the hormonal context. 
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1. Introduction 
The pace of glycolysis and gluconeogenesis regu- 
lated in liver by the availability of substrates, and by 
short-term and long-term control mechanisms [l]. Long- 
term control mainly involves the expression of genes 
encoding glycolytic and gluconeogenic enzymes. 
Hormones play an essential role in the coordinate ex- 
pression of these genes [l], and a full understanding of 
their regulation requires knowledge of the molecular 
mechanisms of hormone action. The bifunctional en- 
zyme 6-phosphofructo-2-kinase (PFK-2, EC 2.7.1.105)/ 
fructose-2,6-bisphosphatase (FBPase-2, EC 3.1.3.46) 
catalyzes the synthesis and degradation of fructose 2,6- 
bisphosphate which, by stimulating 6-phosphofructo-l- 
kinase and inhibiting fructose-l ,6_bisphosphatase, is a 
potent stimulator of glycolysis and inhibitor of glu- 
coneogenesis. There are several PFK-2/FBPase-2 
isozymes with differing expression depending on the tis- 
sue. The liver-, muscle- and fetal-type isozymes are en- 
coded by the same gene which contains 17 exons [2,3]. 
The liver (L), muscle (M) and fetal (F) mRNA each 
originate from a distinct promoter and share exons 2-14, 
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but contain in addition one or more specific exons at 
their 5’ end (Fig. 1). The exon specific for the L mRNA 
contains 346 base pairs and is called exon 1L. 
The activity of the L promoter is controlled by ubiqui- 
tous and liver-specific transcription factors [4,5] and by 
a glucocorticoid responsive unit located in the intron 
downstream of exon 1L [6]. Transcription from the L 
promoter increases upon glucocorticoid treatment of in- 
tact rats [7] and of cultured rat hepatoma Fao cells [S]. 
It also increases in the liver of diabetic rats treated with 
insulin [9,10] and in Fao cells exposed to insulin [8], in 
keeping with the stimulation of glycolysis by insulin [l]. 
However, the effect of insulin on the enzymes involved 
in carbohydrate metabolism is usually opposite to that 
of glucocorticoids [l]. We have re-examined the control 
exerted by these hormones on L mRNA in rat hepatoma 
cells and show that, in fact, insulin opposes the stimula- 
tory effect of the glucocorticoid dexamethasone. 
2. Experimental 
2 1. Cells 
Rat hepatoma FTO-2B cells were grown as monolayers on 60-mm 
dishes in DMEMIHam’s F12 medium supplemented with 10% foetal 
calf serum and used in the logarithmic phase of growth. To test the 
effect of glucose, RPM1 medium containing no glucose or 2 g of glucose 
per 1 was used instead of DMEMIHam’s F12. In some experiments, 
serum was replaced by a solution of 1% bovine serum albumin in 
phosphate buffered saline (final albumin concentration in the medium 
was 0.1%). Dexamethasone was dissolved in ethanol. Insulin was por- 
cine (Actrapid MC, Novo). 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDl 0014-5793(94)00119-G 
222 FP Lemuigre et al. IFEBS Letter.c 340 (IYY4i 11-7/_‘5 
2.2. Plasmlds 
pT7.31388 was constructed by inserting in the X&I and SmaI sites 
of pSP72 (Promega) a 385-bp XbaI-StuI genomic fragment of the 
PFK-2/FBPase-2 gene A [2]. This genomic fragment (positions 3-388 
with respect to the L mRNA cap site) encompasses the liver-specific 
exon 1 L. pT7.31388AR is identical to pT7.3/388 except for a 64-bp 
RsaI-RsaI deletion in the insert. 
2.3. Competitwe reverse transcription-polymerase chain reaction 
(RT-PCR) 
Total cytoplasmic RNA from lo6 to 4 x lo6 FTO-2B cells (test RNA) 
was isolated as follows. The cells were washed and pelleted in phosphate 
buffered saline, and lysed for 5 min on ice in 200 ~1 of a solution 
containing 10 mM Tris-Cl (pH 8.6) 140 mM NaCI, 1.5 mM MgCl,. 1 
mM dithiothreitol, 0.5% NP-40 and 1,000 U/ml human placental ribo- 
nuclease inhibitor. The lysate was centrifugated for 1 min at 10,000 x g 
and the supematant was added to 200 ~1 of a solution containing 200 
mM Tris-Cl (pH 7.4), 25 mM EDTA, 300 mM NaCl, 2% SDS and 100 
,&/ml proteinase K. After a 30-min incubation at 37°C the solution 
was extracted with phenol/chloroform and the RNA was precipitated 
with isopropanol. The RNA pellet was resuspended and incubated for 
1 h at 30°C in 50 ~1 of a solution containing 100 mM sodium acetate 
(pH 5.0), 5 mM MgSO,, and 3 U RNase-free DNase I (Promega) to 
remove traces of cellular DNA. After phenol/chloroform extraction the 
RNA was precipitated with isopropanol, resuspended in double dis- 
tilled water and quantified by spectrophotometry. The integrity of the 
RNA preparations was checked by visualizing the 28 S and 18 S rRNA 
on agarose gels. Internal standard RNA was synthesized in vitro by 
transcribing with T7 RNA polymerase the pT7.3/388DR plasmid lin- 
earized with PvuII. This yielded a 370 base RNA that was treated with 
DNase I under the same conditions as the test RNA. This RNA encom- 
passes nucleotides 3-388 of exon 1L but contains a 64-bp deletion 
between nucleotides 59 and 124. Reverse transcription with random 
hexamers and PCR reactions were performed with a RNA-AMP kit 
(Perkin Elmer-Cetus) under the conditions described by the manufac- 
turer. Each reaction contained 500 ng of test RNA and 0.04 pg of 
internal standard RNA. After reverse transcription, the test and inter- 
nal standard cDNAs were competitively co-amplified by PCR with 
primers that hybridize to nucleotides +32 to +49 and to nucleotides 
+284 to +305 (Fig. 1). This yielded products of 274 and 210 bp corre- 
sponding to amplified exon 1L and internal standard, respectively. The 
5’-3’ sequence of the PCR primers was GGCTCTCAGCACCCACAT 
(5’ primer) and GGAATCCAGATCTTCTGTAACC (3’ primer). For 
PCR 30 cycles were performed at 94°C (1 min), 5 1°C (1 min) and 72” C 
(1 min). To check for RNA or DNA contaminations RT-PCR was 
performed either in the absence of RNA or in the absence of reverse 
transcriptase. The quantification of the RT-PCR reactions was per- 
formed by adding 2 PCi of [a-3*P]dCTP during the amplification. The 
PCR products were separated on 2% agarose gels from which the bands 
were cut out and counted by scintillation. All experiments were per- 
formed at least twice. 
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Fig. 1. Structure of the PFK-ZIFBPase-2 gene A and of the F-, L- and 
M-type mRNAs. Boxes represent exons and arrows indicate transcrip- 
tion initiation sites. The lower part of the figure shows the position of 
the primers and the structure of the internal standard RNA used in the 
RT-PCR assays. 
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Fig. 2. Insulin reverses the increase in PFK-Z/FBPase-2 L mRNA 
induced by dexamethasone. (A) Effect of 1 PM dexamethasone on L 
mRNA abundance as a function of time. (B) Reversal by 10 nM insulin 
of the glucocorticoid-induced stimulation. The abundance of the PFK- 
Z/FBPase-2 L mRNA is expressed as the ratio of the cDNAs amplified 
by PCR from the RNA corresponding to exon 1 L (L) and to the 
internal standard (St). Fixed amounts of internal standard RNA (0.04 
pg) and of test RNA (500 ng) were used in all reactions. The insets show 
photographs of the agarose gels stained with ethidium bromide. The 
L/st ratio was calculated from the radioactivity incorporated m the 
PCR products. 
3. Results and discussion 
Because the mRNAs from gene A are rare and the L 
specific region is limited to exon 1L it is difficult to 
quantitate L mRNA concentration by conventional hy- 
bridization techniques. We have therefore resorted to the 
sensitive competitive reverse transcription (RT)-polym- 
erase chain reaction (PCR) assay. This technique enables 
one to quantify the test mRNA, as the amount of inter- 
nal standard RNA for which equimolar quantities of test 
and internal standard PCR products are obtained is 
equal to the amount of test mRNA [ 111. To detect varia- 
tions in L mRNA content, we mixed a fixed amount of 
RNA extracted from FTO-2B cells with a fixed amount 
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Fig. 3. Dose-dependence of the inhibitory effect of insulin. The cells were incubated for 24 h with hormones, added alone or simultaneously as 
indicated, and the abundance of PFK-ZIFBPase-2 L mRNA was visualised and expressed as in Fig. 2. 
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of internal standard RNA and measured the ratio of test 
and internal standard products. Variations of this ratio 
(L/St) reflect variations in L mRNA concentration in the 
cells. 
To assess the validity of this method, we first measured 
the variation in L mRNA as a function of time after 
incubation of the FTO-2B cells with 1 PM dexam- 
ethasone (Fig. 2A). This showed an increase in L mRNA 
concentration after 1 h, followed by a steady rise until 
a maximum was reached after 32 h of incubation with the 
hormone. The maximal stimulation was about ten-fold, 
as determined in separate RT-PCR experiments where 
the cellular L mRNA was titrated against the internal 
standard (not shown). A dose-response curve showed 
that maximal stimulation was obtained at a dexam- 
ethasone concentration of 10 nM (not shown). We con- 
clude from these experiments that FTO-2B cells express 
the PFK-2/FBPase-2 L mRNA and that the concentra- 
tion of this mRNA increases upon glucocorticoid treat- 
ment, as expected. 
To test the effect of insulin, cells were incubated for 
2-24 h with a saturating concentration (10 nM). No 
reproducible effect of insulin alone on L mRNA could 
be detected (not shown). However, insulin exerted a 
striking inhibitory effect on the dexamethasone stimula- 
tion. Fig. 2B shows a representative xperiment in which 
cells were treated with 1 ,uM dexametha-sone for 24 h. 
After this period, 10 nM insulin was added to the me- 
dium containing dexamethasone and the cells were col- 
lected at several time-points. One sees that L mRNA 
concentration decreased after 2 h to reach, after 8 h, a 
value close to the unstimulated level. This inhibitory 
effect was also observed in cells grown in medium de- 
pleted of serum starting 24 h prior to adding dexam- 
ethasone (not shown). 
The effect of insulin was dose-dependent. Cells were 
incubated for 24 h with 1 PM dexamethasone alone or 
with dexamethasone and different concentrations of in- 
sulin. Fig. 3 shows that glucocorticoid stimulation was 
inhibited at 0.1 nM insulin and that maximal inhibition 
was obtained at 10 nM. This effect of insulin is therefore 
observed in the physiological concentration range. 
To determine whether insulin affected the degradation 
rate of the L mRNA, we stimulated the cells for 24 h with 
1 ,uM dexamethasone, and then added the transcription 
inhibitor actinomycin D (5 &ml) with or without 10 nM 
insulin (Fig. 4). The cells were harvested at several time- 
points to measure L mRNA concentration. Insulin did 
not influence the degradation rate of L mRNA under 
conditions in which gene transcription was blocked. This 
experiment did not exclude the possibility that insulin 
induces, via an actinomycin D-sensitive step, the synthe- 
sis of a short-lived protein that accelerates L mRNA 
degradation. We therefore tested whether the inhibitory 
effect of insulin required ongoing protein synthesis. 
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Fig. 4. Insulin does not influence L mRNA degradation. The cells were 
treated with 1 PM dexamethasone, 10 nM insulin, and actinomycin D 
(5 fig/ml) as indicated. ‘d’ and ‘di’ point to dexamethasone and dexam- 
ethasone + insulin-treated samples, respectively. L mRNA abundance 
is expressed as in Fig. 2. 
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Fig. 5. Inhibition by insulin of the glucocorticoid-induced increase in 
L mRNA does not require ongoing protein synthesis. Cells were treated 
with hormones and cycloheximide (CHX) as explamed in the text. L 
mRNA abundance is expressed as in Fig. 2. 
FTO-2B cells were incubated for 24 h with 1 FM dexam- 
ethasone following which 10 nM insulin was added in the 
presence of the protein synthesis inhibitor cyclo- 
heximide. Cycloheximide (10 PM) was added 15 min 
before insulin and the cells collected 4 h after addition 
of insulin. As shown in Fig. 5, the insulin-induced inhibi- 
tion was independent of protein synthesis. We conclude 
from these experiments that insulin does not affect the 
degradation rate of L mRNA and therefore exerts its 
effect at the level of transcription. 
There are two modes of action of insulin on gene 
transcription [l]. The response of some genes, such as 
those encoding glucokinase and phosphoenolpyruvate 
carboxykinase, is fast and is independent of protein syn- 
thesis and of the presence of glucose [ 12,131. The effect 
on other genes, such as those encoding aldolase B and 
pyruvate kinase, is slow in onset and requires glucose 
and ongoing protein synthesis [14]. Data in Figs. 2 and 
5 show that the inhibition exerted by insulin on glucocor- 
ticoid induction of the L mRNA was fast and independ- 
ent of protein synthesis. We therefore tested whether 
glucose was required for this effect of insulin. The cells 
were grown for 24 h without hormones, with dexam- 
ethasone alone, or with dexamethasone plus insulin, in 
medium containing glucose (2 g/l) or not. As shown in 
Fig. 6 glucose was not required for the inhibitory effect 
of insulin. 
In conclusion, we demonstrate here that rat hepatoma 
FTO-2B cells express the PFK-2/FBPase-2 L mRNA 
and that glucocorticoids increase its concentration as 
expected from the stimulation of transcription described 
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in rat liver [7] and Fao hepatoma cells [8]. We also show 
that insulin can prevent and reverse this effect. Glucocor- 
ticoids exert a net gluconeogenic effect by stimulating the 
activity of transaminases, phosphoenolpyruvate car- 
boxykinase and glucose-6-phosphatase [ 151. As the phys- 
iological effect of insulin in liver is to stimulate glycoly- 
sis, it is not surprising that insulin opposes the effect of 
glucocorticoids as we show here. Thus, the pattern of 
hormonal regulation of PFK-2/FBPase-2 L mRNA re- 
sembles that of the gluconeogenic enzymes. The increase 
of PFK-2/FBPase-2 mRNA content in the liver of rats 
treated with glucocorticoids correlates with an increase 
in fructose 2,6-bisphosphate content [7]. This in turn 
could result in an increase in substrate cycling that may 
lead to amplification of gluconeogenesis. Insulin alone. 
i.e. in the absence of glucocorticoids. stimulates tran- 
scription of the L type PFK-2/FBPase-2 mRNA two- to 
four-fold [8]. We did not observe such an effect, probably 
because RT-PCR does not detect low levels of stimula- 
tion. The fact that insulin stimulates, even weakly, tran- 
scription from the PFK-2/FBPase-2 L promoter when 
used alone, and inhibits transcription when combined 
with a glucocorticoid, shows that insulin can exert oppo- 
site effects on the same gene depending on the hormonal 
status. A similar phenomenon has been described for the 
gene encoding tyrosine aminotransferase [ 16,171. 
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Fig. 6. Inhibition by insulin of the glucocorticoid-induced increase in 
L mRNA does not depend on extracellular glucose. Cells were treated 
for 24 h with dexamethasone alone or with a mixture of dexamethasone 
and insulin in the absence or presence of glucose (2 g/l), as indicated. 
L mRNA abundance is expressed as in Fig. 2. 
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